Insurers Deny Cancer Pills Up to 84% of the Time, Call It Process
The real story: Blood Cancer Drug Denials; Body Fat and Pancreas Cancer; Studies With Fake Citations MedPage Today · Oct 23, 2026
Our take: Up to 84% of specialty oral blood cancer prescriptions were initially denied, which suggests the prior authorization form is the only treatment guaranteed to be refractory. Somewhere a clinician is on hold, rehearsing the peer-to-peer. The pill works fine. The paperwork is what's being titrated.